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Pathways in Human Lymphocytes
Abstract
Leukotoxin (LtxA), from oral pathogen Aggregatibacter actinomycetemcomitans, is a secreted
membrane-damaging protein. LtxA is internalized by β2 integrin LFA-1 (CD11a/CD18)-expressing
leukocytes and ultimately causes cell death; however, toxin localization in the host cell is poorly
understood and these studies fill this void. We investigated LtxA trafficking using multi-fluor confocal
imaging, flow cytometry and Rab5a knockdown in human T lymphocyte Jurkat cells. Planar lipid bilayers
were used to characterize LtxA pore‐forming activity at different pHs. Our results demonstrate that the
LtxA/LFA-1 complex gains access to the cytosol of Jurkat cells without evidence of plasma membrane
damage, utilizing dynamin-dependent and presumably clathrin-independent mechanisms. Upon
internalization, LtxA follows the LFA‐1 endocytic trafficking pathways, as identified by co-localization
experiments with endosomal and lysosomal markers (Rab5, Rab11A, Rab7, and Lamp1) and CD11a.
Knockdown of Rab5a resulted in the loss of susceptibility of Jurkat cells to LtxA cytotoxicity, suggesting
that late events of LtxA endocytic trafficking are required for toxicity. Toxin trafficking via the degradative
endocytic pathway may culminate in the delivery of the protein to lysosomes or its accumulation in
Rab11A‐dependent recycling endosomes. The ability of LtxA to form pores at acidic pH may result in
permeabilization of the endosomal and lysosomal membranes. © 2020 by the authors. Licensee MDPI,
Basel, Switzerland.
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Abstract: Leukotoxin (LtxA), from oral pathogen Aggregatibacter actinomycetemcomitans, is a secreted
membrane-damaging protein. LtxA is internalized by β2 integrin LFA-1 (CD11a/CD18)-expressing
leukocytes and ultimately causes cell death; however, toxin localization in the host cell is poorly
understood and these studies fill this void. We investigated LtxA trafficking using multi-fluor confocal
imaging, flow cytometry and Rab5a knockdown in human T lymphocyte Jurkat cells. Planar lipid
bilayers were used to characterize LtxA pore-forming activity at different pHs. Our results demonstrate
that the LtxA/LFA-1 complex gains access to the cytosol of Jurkat cells without evidence of plasma
membrane damage, utilizing dynamin-dependent and presumably clathrin-independent mechanisms.
Upon internalization, LtxA follows the LFA-1 endocytic trafficking pathways, as identified by
co-localization experiments with endosomal and lysosomal markers (Rab5, Rab11A, Rab7, and
Lamp1) and CD11a. Knockdown of Rab5a resulted in the loss of susceptibility of Jurkat cells to LtxA
cytotoxicity, suggesting that late events of LtxA endocytic trafficking are required for toxicity. Toxin
trafficking via the degradative endocytic pathway may culminate in the delivery of the protein to
lysosomes or its accumulation in Rab11A-dependent recycling endosomes. The ability of LtxA to
form pores at acidic pH may result in permeabilization of the endosomal and lysosomal membranes.
Keywords: Aggregatibacter actinomycetemcomitans; RTX toxin; localized aggressive periodontitis;
LFA-1; leukotoxin (LtxA); endocytosis

1. Introduction
The RTX (Repeats in ToXin) toxins are membrane-damaging proteins secreted by some
Gram-negative bacteria [1]. The organisms producing these proteins are important human and
animal pathogens, implicating the toxins’ role in the bacterial virulence. RTX toxins’ common features
are using the type I secretion system as a mode of export across the bacterial envelope, employing
an uncleaved C-terminal recognition signal [2–4], and the characteristic nonapeptide glycine- and
aspartate-rich repeat binding of Ca2+ ions [5,6]. The toxins are modified with fatty acid moieties
attached to internal lysine residues, which is an unusual characteristic for bacterial proteins [7–10].
RTX toxins can be divided into three groups: (i) broadly cytolytic RTX hemolysins, (ii) species-specific
RTX leukotoxins, and (iii) large, multifunctional, autoprocessing RTX toxins (MARTX) [1]. RTX
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leukotoxins exhibit a narrow cell type and species specificity due to cell-specific binding through
protein receptors of the β2 integrin family [1]. The β2 integrins are expressed on the surface of
leukocytes and share a common β2 subunit, CD18, which is combined with either one of the unique α
chains, αL (CD11a), αM (CD11b), αX (CD11c), or αD (CD11d) [11].
Aggregatibacter actinomycetemcomitans (Aa), a facultative anaerobe and common inhabitant of the
human aerodigestive tract, causes localized aggressive periodontitis (LAP) [12]. LAP is a rapidly
progressing periodontal disease that results in loss of tooth attachment and alveolar bone destruction
in adolescents. If left untreated in teenagers, the infection will lead to the loss of the permanent first
molars and central incisors [13]. Recent data indicate that Aa plays a role in the early stages of the
disease. Specific Aa virulence factors can trigger the disease by suppressing the host response, which
will allow for the overgrowth of Aa and other “toxic” bacteria in the local environment [12]. The pivotal
virulence factor of Aa is an RTX leukotoxin, LtxA, that kills both human innate and adaptive immune
cells [14]. Aa isolated from LAP patients predominantly belongs to a single clone, JP2 [15], which is
characterized by increased LtxA production, implicating a role for LtxA in disease development [16].
Analysis of a primary LtxA sequence consisting of 1055 amino acids predicts four LtxA domains [17].
The hydrophobic domain encompasses residues 1–420 and incorporates cholesterol recognition amino
acid consensus (CRAC) [18]. CRAC motif mediates LtxA binding to cholesterol and is essential for LtxA
association with the plasma membrane of human T lymphocytes and monocytes [18,19]. The central
domain (residues 421–730) contains two internal lysine residues (K562 and K687 ) that are the sites of
post-translational acylation, required for LtxA activation [9]. The repeat domain (residues 731–900)
contains the typical repeated amino acid sequence of the RTX family with the C-terminal domain
(residues 901–1055), and is believed to play a role in secretion [17].
Recent findings suggest that recirculating and resident memory T cells in gingival tissue play an
important role in the maintenance of periodontal homeostasis [20]. In an experimental rat periodontal
disease model, antigen-specific CD4 T lymphocytes were required for bone resorption [21]. Hence,
the investigation of the LtxA effect on T lymphocytes is important for our understanding of how Aa
causes periodontal disease. In our previous studies, the Jurkat cell line, subclone Jn.9, served as a
model to study LtxA interaction with T lymphocytes’ cell membrane. Jn.9 cells express cell-surface
LFA-1 and are susceptible to LtxA-induced toxicity [22]. LtxA toxicity requires the presence of the
β2 integrin LFA-1(LFA-1, CD11a/CD18 or αL /β2 ) and cholesterol on the surface of Jn.9 cells [18,23,24].
LFA-1 is a native ligand for intercellular adhesion molecule (ICAM-1) located on vascular endothelial
cells [25]. In immunocytes, LFA-1/ICAM-1 binding is one of the molecular mechanisms for leukocyte
adhesion and migration to the site of infection [26]. LFA-1 is constantly endocytosed and then rapidly
recycled back to the plasma membrane through vesicular transport [27,28] using the “long-loop” of
recycling involving GTPase Rab11A-positive endosomes [29]. Also, LFA-1 activity is regulated by the
ability of these receptors to switch between active and inactive conformations [25].
In the proposed mechanism of LtxA interaction with the Jn.9 cells membrane, the initial binding
of the toxin with the membrane elevates cytosolic Ca2+ independent of the toxin binding to LFA-1.
Ca2+ elevation involves the activation of calpain and talin cleavage, and the subsequent clustering of
LFA-1 in lipid rafts on the membrane [24]. LtxA binds to the extracellular domains of LFA-1 subunits,
CD11a and CD18. The toxin then transverses the cell membrane, binds to the cytoplasmic tails of
LFA-1, and causes activation of LFA-1 [23]. Following from the results of the liposomal study, LtxA
adopts a U-shaped conformation in the membrane, with the N- and C-terminal domains residing
outside of the membrane [30].
After binding to the LFA-1 subunits, LtxA is quickly internalized into the cytosol, where it is
found in vesicular structures [23]. Since LtxA binds to LFA-1, there is a possibility that LtxA could be
using an integrin endocytic trafficking pathway to gain access to the target cell cytosol. The mechanism
of LtxA uptake and the pathway of intracellular toxin trafficking has not been investigated. Here,
we examined the components of the cytosol of LtxA-treated cells for co-localization of the toxin and
the CD11a subunit of LFA-1 with different organelle markers. LtxA association with endosomal and

Pathogens 2020, 9, 74

3 of 23

lysosomal markers suggests a receptor-mediated endocytic process that may culminate in the delivery
of the toxin to lysosomes. Additionally, the toxin can be redirected to the plasma membrane due to
the LFA-1 receptor Rab11A-mediated recycling. This study provides new insight into convergent
mechanisms of LFA-1 and LtxA trafficking, and the ability of LtxA to function in acidic environments.
2. Results
2.1. LtxA Does Not Damage Host Cell Membrane When Entering the Cell
The membrane damaging properties of LtxA have been documented [31,32]. Therefore, the first
question we asked was whether the initial steps of LtxA interaction with the cells result in the plasma
membrane damage. The green-fluorescent impermeable nucleic acid stain YO-PRO®-1 is used to
detect early membrane damage as it permeates cells immediately after membrane destabilization [33].
Propidium iodide (PI) is used to identify late cell death in which the integrity of the plasma and
nuclear membranes significantly decreases, allowing PI to penetrate the membranes and intercalate
into nucleic acids [34]. To study the effect on membrane permeability, we first incubated Jn.9 cells with
20 nM LtxA at different times over a 10 h time period, and then flow cytometry analysis of LtxA-treated
cells was performed to determine YO-PRO®-1 and PI internalization. The YO-PRO®-1 membrane
permeabilization assay showed no evidence of plasma membrane damage in LtxA-treated Jn.9 cells
at least within first 3 h of treatment (Figure 1A,B). However, our flow cytometry data demonstrated
that 20 nM LtxA-DY488 became internalized with Jn.9 cells 30 min after the toxin was added and
internalization steadily increased over time (Figure 1A,B). Lymphocytes are known to be moderately
susceptible to LtxA and are killed by apoptosis [35]. The staining of Jn.9 cells with PI was observed
after 10 h of treatment with LtxA, suggesting that cells are in the late apoptotic stage (Figure 1B). Hence,
our data indicate that LtxA is quickly internalized by Jn.9 cells but the toxin does not rupture the
plasma membrane when it enters the host cells.
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2.2. LtxA Uptake is Diminished by Dynamin Inhibitors
We hypothesized that LtxA could get access to the cytosol of Jn.9 cells through endocytic uptake.
The exposure of cells to cold temperatures is used for the nonspecific inhibition of endocytosis [36].
Therefore, we treated Jn.9 cells with fluorescent-labeled LtxA in ice-cold medium and analyzed the
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2.2. LtxA Uptake is Diminished by Dynamin Inhibitors
We hypothesized that LtxA could get access to the cytosol of Jn.9 cells through endocytic uptake.
The exposure of cells to cold temperatures is used for the nonspecific inhibition of endocytosis [36].
Therefore, we treated Jn.9 cells with fluorescent-labeled LtxA in ice-cold medium and analyzed the toxin
entry to cells by flow cytometry and confocal microscopy. We demonstrated that cold temperatures
affected the binding of and slowed down internalization of the toxin with Jn.9 cells (Figure 2A, Figure
S1). We then set up an experiment employing a set of chemical and pharmacological inhibitors of
endocytosis (Table 1) to define the mechanism of the toxin uptake by the cells. The effect of dynamin- and
clathrin-mediated endocytosis inhibitors on transferrin uptake is well established [37,38]. To confirm
the efficiency and select the inhibitors’ concentrations for our study, the internalization of transferrin
conjugated to Alexa Fluor®555 and LtxA-DY650 by Jn.9 cells was followed using confocal microscopy
Figure S2. At 10 µM Dynasore, 10 µM Dynole 34-2 and 5 µM Pitstop 2, the inhibitory effect on transferrin
uptake was observed. First, we wanted to identify whether GTPase dynamin activity is essential for
LtxA uptake. The LtxA-DY650 internalization in the presence of dynamin inhibitor 10 µM Dynasore
was evaluated by live confocal imaging (Figure S3) and flow cytometry analysis (Figure 2C). To confirm
our results, we performed flow cytometry analysis in cells treated with another dynamin inhibitor,
10 µM Dynole 34-2, which blocks the GTPase activity of dynamin [37,39]. Fluorescent-labeled toxin
internalization was significantly reduced in cells pre-treated with dynamin-inhibitors. Cells pretreated
with 10 µM Dynasore and Dynole 34-2 for 20 min internalized much less LtxA (Figure 2C). However,
the inactive control for Dynole 34-2, Dynole 31-2, did not inhibit the toxin internalization. The inhibitors
affecting the clathrin-mediated endocytic pathway, such as potassium-depleted medium [40] and
5 µM Pitstop 2 [41], did not change the efficiency of LtxA internalization with Jn.9 cells (Figure 2B,C).
Collectively, these data suggest that LtxA internalization with Jn.9 cells is dynamin-dependent and
predominantly clathrin-independent. Next, we evaluated the toxicity of LtxA on Jn.9 cells containing
the above inhibitors. However, we identified some toxic effect of endocytosis inhibitors on Jn.9 cells.
After 18 h of treatment with the 2 nM toxin, we observed some decrease in LtxA toxicity on Jn.9 cells
pretreated with 10 µM Dynasore and 10 µM Dynole 34-2 (Figure S4), suggesting that these compounds
could attenuate LtxA intoxication.
Table 1. Chemical inhibition of LtxA uptake.
Compound

Mode of Action

Effect on Internalization

10 µM Dynasore *
10 µM Dynole 34-2 *
10 µM Dynole 31-2 *

Blocks GTPase activity of dynamin [37]
Blocks GTPase activity of dynamin [39]
Inactive derivative of Dynole 34-2
Interferes with binding of proteins to the
N-terminal domain of clathrin [41]
Inhibits clathrin mediated endocytosis [40]

Inhibits
Inhibits
No effect

5 µM Pitstop 2 *
K+ -depletion

No effect
No effect

* To measure LtxA internalization inhibition, Jn.9 cells were preincubated with 5–10 µM inhibitors for 20 min in
serum free medium. The 0.5–1 mM chemical stocks were prepared in dimethyl sulfoxide (DMSO) and were added
in the 1 µl volume to 1 ml of cells. No adverse effect of DMSO alone on Jn.9 cells was observed.

that LtxA internalization with Jn.9 cells is dynamin-dependent and predominantly clathrinindependent. Next, we evaluated the toxicity of LtxA on Jn.9 cells containing the above inhibitors.
However, we identified some toxic effect of endocytosis inhibitors on Jn.9 cells. After 18 h of
treatment with the 2 nM toxin, we observed some decrease in LtxA toxicity on Jn.9 cells pretreated
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and 10 µM Dynole 34-2 (Figure S4), suggesting that these compounds could
attenuate LtxA intoxication.

Figure 2. Effect of endocytosis inhibitors on LtxA internalization. (A). Flow cytometry analysis of LtxA
internalization with Jn.9 cells at different temperatures. The cells were treated with LtxA-DY488 for
30 min on ice or 37 ◦ C. In a set of cells, the total cell-associated fluorescence was measured by flow
cytometry analysis (shown in red). In another set of cells, the extracellular fluorescence was quenched
(0.025% trypan blue) [42] and intracellular fluorescence (red peak) was determined by flow cytometry
analysis. (B). Flow cytometry analysis of LtxA internalization with Jn.9 cells in K+ -free buffer. Jn.9 cells
(1 × 106 ) were incubated in K+ -containing (top) or K+ -free buffer (bottom), and then 20 nM LtxA-DY488
was added for 30 min. Flow cytometry analysis to determine the amount of internalized toxin (red peak)
was performed as described in Figure 2A. (C). Flow cytometry analysis of LtxA-DY488 internalization
with Jn.9 cells pretreated with chemical inhibitors. Jn.9 cells (1 × 106 ) were preincubated with 5–10 µM
endocytosis inhibitors for 20 min in serum free medium, and then were treated with 20 nM LtxA-DY488
for 30 min at 37 ◦ C. The extracellular fluorescence was quenched 0.025% trypan blue, and intracellular
fluorescence (red peak) was determined by flow cytometry analysis.

2.3. LtxA and CD11a Are Found in Early and Recycling Endosomes
In our imaging studies, LtxA was found in vesicular structures after entry into Jn.9 cells [23].
The co-distribution of LtxA and LFA-1 heterodimer components on the surface of target cell membranes
indicates that LtxA could intrude into the cytosol as individual LtxA molecules or as part of an
LtxA/LFA-1 complex. In order to characterize LtxA-containing endocytic vesicles, Jn.9 cells were
treated with fluorescent-labeled LtxA for 30 min and were used to perform immunocytochemistry
experiments with endocytic pathway markers, including GTPase Rab5 and Rab11A. Our imaging
studies demonstrated the abundant colocalization of LtxA, early endosome membrane protein Rab5
and CD11a, suggesting toxin uptake through receptor-mediated endocytosis. Figure 3 and Figure S5
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show confocal images of Jn.9 cells with a co-localization of LtxA, CD11a, and Rab5 after treatment of
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Figure 3. LtxA localization in early endosomes of Jn.9 cells. The cells were treated with 20 nM LtxA for
Figure 3. LtxA localization in early endosomes of Jn.9 cells. The cells were treated with 20 nM LtxA
30 min at 37 ◦ C. (A). 3D confocal images showing the distribution of LtxA, CD11a and Rab5. LtxA is
for 30 min at 37 °C. A. 3D confocal images showing the distribution of LtxA, CD11a and Rab5. LtxA
pseudo colored in red and CD11a is in red or green (pseudo colored), as indicated on images. The 3D
is pseudo colored in red and CD11a is in red or green (pseudo colored), as indicated on images. The
images were reconstructed from seventeen confocal planes using Nikon Elements AR 4.30.01 software.
3D images were reconstructed from seventeen confocal planes using Nikon Elements AR 4.30.01
Bounding box dimensions are: width 14.19 µm; height 17.30 µm; depth 5.20 µm. (B). Localization
software. Bounding box dimensions are: width 14.19 µm; height 17.30 µm; depth 5.20 µm. B.
of LtxA-DY650 is shown in cyan, CD11a recognized with mouse Alexa Fluor™ 594 clone HI111 is
Localization of LtxA-DY650 is shown in cyan, CD11a recognized with mouse Alexa Fluor™ 594 clone
shown in red, and Rab5, recognized by rabbit anti-Rab5 antibody followed by staining with anti-rabbit
HI111 is shown in red, and Rab5, recognized by rabbit anti-Rab5 antibody followed by staining with
IgG Alexa Fluor®488, is shown in green. The nucleus was stained with Hoechst dye and is shown in
anti-rabbit IgG Alexa Fluor®488, is shown in green. The nucleus was stained with Hoechst dye and
blue. (C). Top: Merged image “B” showing colocalization of LtxA DY650 (cyan), CD11a (red) and Rab5
is shown in blue. C. Top: Merged image “B” showing colocalization of LtxA DY650 (cyan), CD11a
(green). Bottom: Intensity profiles for LtxADY650 (cyan), CD11a (red) and Rab5 (green) across the line
(red) and Rab5 (green). Bottom: Intensity profiles for LtxADY650 (cyan), CD11a (red) and Rab5
depicted in the image above. The degree of overlap in the LtxA-containing area was estimated with
(green) across the line depicted in the image above. The degree of overlap in the LtxA-containing area
the Pearson’s correlation coefficient in the LtxA-containing area of 0.78 for LtxA and Rab5, 0.68 for
was estimated with the Pearson’s correlation coefficient in the LtxA-containing area of 0.78 for LtxA
LtxA and CD11a, and of 0.88 for CD11a and Rab5. Representative cells are shown. Additional data are
and Rab5, 0.68 for LtxA and CD11a, and of 0.88 for CD11a and Rab5. Representative cells are shown.
shown in Figure S5.
Additional data are shown in Figure S5.

LFA-1 is exocytosed via GTPase Rab11A-mediated recycling [43] a process that involves trafficking
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Alternatively, the release of LtxA into PNRC can provide access to the nuclear membrane for LtxA.
Indeed, in our imaging studies we often observed the toxin surrounding nuclei (Figure S7).
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Figure 4. LtxA localization in Rab11A-positive endosomes of Jn.9 cells. The cells were treated with
Figure 4. LtxA localization in Rab11A-positive endosomes of Jn.9 cells. The cells were treated with 20
20 nM LtxA for 30 min at 37 ◦ C. (A). 3D confocal images showing the distribution of LtxA, CD11a and
nM LtxA for 30 min at 37 °C. A. 3D confocal images showing the distribution of LtxA, CD11a and
Rab11A. LtxA is pseudo colored in red and CD11a is in red or green (pseudo colored), as indicated
Rab11A. LtxA is pseudo colored in red and CD11a is in red or green (pseudo colored), as indicated
on images. The 3D images were reconstructed from seventeen confocal planes using Nikon Elements
on images. The 3D images were reconstructed from seventeen confocal planes using Nikon Elements
AR 4.30.01 software. Bounding box dimensions are: width 22.58 µm; height 16.47 µm; depth 5.20 µm.
AR 4.30.01 software. Bounding box dimensions are: width 22.58 µm; height 16.47 µm; depth 5.20 µm.
(B). Localization of LtxA-DY650 is shown in cyan, CD11a recognized with mouse Alexa Fluor™ 594
B. Localization of LtxA-DY650 is shown in cyan, CD11a recognized with mouse Alexa Fluor™ 594
clone HI111 is shown in red, and Rab11A, recognized by rabbit anti-Rab11A antibody followed by
clone HI111 is shown in red, and Rab11A, recognized by rabbit anti-Rab11A antibody followed by
staining with anti-rabbit IgG Alexa Fluor®488, is shown in green. The nucleus was stained with
staining with anti-rabbit IgG Alexa Fluor®488, is shown in green. The nucleus was stained with
Hoechst dye and is shown in blue. (C). Top: Merged image “B” showing co-localization of LtxA DY650
Hoechst dye and is shown in blue. C. Top: Merged image “B” showing co-localization of LtxA DY650
(cyan), CD11a (red) and Rab11A (green). Bottom: Intensity profiles for LtxADY650 (cyan), CD11a
(cyan), CD11a (red) and Rab11A (green). Bottom: Intensity profiles for LtxADY650 (cyan), CD11a
(red) and Rab11A (green) across the line depicted in the image above. The degree of overlap in the
(red) and Rab11A (green) across the line depicted in the image above. The degree of overlap in the
LtxA-containing area was estimated with the Pearson’s correlation coefficient of 0.75 for LtxA and
LtxA-containing area was estimated with the Pearson’s correlation coefficient of 0.75 for LtxA and
Rab11A, 0.72 for LtxA and CD11a, and of 0.76 for CD11a and Rab11A. Representative cells are shown.
Rab11A, 0.72 for LtxA and CD11a, and of 0.76 for CD11a and Rab11A. Representative cells are shown.
Additional data are shown in Figure S6.
Additional data are shown in Figure S6.

2.4. LtxA and CD11a Are Found in Late Endosomes and Lysosomes
2.4. LtxA and CD11a Are Found in Late Endosomes and Lysosomes
At later timepoints, Jn.9 cells treated with fluorescent-labeled LtxA were used in immunocytochemistry
At laterwith
timepoints,
Jn.9pathway
cells treated
fluorescent-labeled
used in
experiments
the endocytic
markers with
GTPases
Rab7 and Lamp1. LtxA
After 1were
h of treatment
immunocytochemistry
experiments
with
the
endocytic
pathway
markers
GTPases
Rab7
and
Lamp1.
with LtxA-DY650, LtxA was associated with the late endosome membrane protein Rab7 (Figure
5
After 1 h of treatment with LtxA-DY650, LtxA was associated with the late endosome membrane
protein Rab7 (Figure 5 and Supplemental Figure S8). Colocalization was detected in approximately
1/10 of LtxA-containing spots. Colocalization of LtxA with lysosomal marker Lamp1 after 2 h of
treatment with LtxA-DY650 indicated that the toxin trafficking culminates in its delivery to the
lysosomes, where LtxA was found separated from CD11a (Figure 6 and Figure S9).
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2.5. Rab5 siRNA Knockdown limits LtxA Toxicity
Irrespective of routes of internalization, endocytic cargoes are trafficked to early endosomes,
where Rab5 GTPases is the key player in subsequent trafficking events [44]. We investigated the impact
of Rab5a downregulation on LtxA uptake and toxicity on cells (Figure 7). Western blot analysis 24 h
after transfection with Rab5a siRNA confirmed that Rab5a was significantly downregulated (≥ 90%)
in Jn.9 cells compare to scrambled siRNA transfected cells. When transfected cells were treated with
20 nM LtxA for 18 h, the toxic effect of the toxin on Rab5a downregulated cells was 30% less than
on control cells (Figure 7A). Internalization of LtxA was analyzed by flow cytometry after 30 min of
treatment with 20 nM LtxA-DY488. No significant variations in the amount of internal fluorescence
were detected in cells transfected with Rab5a siRNA (mean channel fluorescence (MCF) 28.2 ± 0.6) and

impact of Rab5a downregulation on LtxA uptake and toxicity on cells (Figure 7). Western blot
analysis 24 h after transfection with Rab5a siRNA confirmed that Rab5a was significantly
downregulated (≥ 90%) in Jn.9 cells compare to scrambled siRNA transfected cells. When transfected
cells were treated with 20 nM LtxA for 18 h, the toxic effect of the toxin on Rab5a downregulated cells
was 30% less than on control cells (Figure 7A). Internalization of LtxA was analyzed by flow
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indicate that this is likely because of a rise in pH in intact lysosomes. A decrease in Lamp1 intensity
would suggest that change in lysosomal pH is due to lysosomal rupture (Figure 8B).

about 15% decrease in the intensity was identified in Jn.9 cells after 2 h of treatment (Figure 8A),
which may indicate lysosomal damage due to lysosomal membrane permeabilization or lysosome
alkalization. In order to assess if LtxA causes the rupture of lysosomes, we identified the intensity of
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rather small on the conductance of the LtxA channel, despite a possible shift of the selectivity of the
1 M KCl, 10 mM MES-KOH
3.7
1.0 ± 0.21
12
LtxA channel from being slightly cation selective at pH 6.0 to a higher selectivity for potassium ions
1 M KCl, 10 mM MES-KOH
4.7
1.1 ± 0.31
47
over chloride.
1 M KCl, 10 mM MES-KOH
6.0
1.2 ± 0.30
95
No1residual
fluorescence
X-100 permeabilized cells39
after the trypan
M KCl, 10
mM Tris-HClwas detected
7.5in 0.1% Triton
1.2 ± 0.24
blue treatment.
Untreated
cells (blue or 8.5
black) served
a negative control. Representative
flow
1 M KCl, 10
mM Tris-HCl
1.3 as
± 0.29
53
cytometry
shown.
1 Mhistograms
KCl, 10 mMare
Tris-HCl
10
1.2 ± 0.26
14
* The LtxA conductance (G ± variance/SD) in each 1 M KCl solution was either taken from Gaussian
distributions (see Figure 9) or directly from the statistics of single-channel data (n number of single
events). To analyze the conductance in each case, n channels were reconstituted in asolectin/n-decane
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Table 2. Influence of the aqueous pH on the conductance of channels formed by LtxA.
Salt and Buffer

pH

G * ± SD (nS)

Number of Events (n)

1 M KCl, 10 mM MES-KOH
1 M KCl, 10 mM MES-KOH
1 M KCl, 10 mM MES-KOH
1 M KCl, 10 mM Tris-HCl
1 M KCl, 10 mM Tris-HCl
1 M KCl, 10 mM Tris-HCl

3.7
4.7
6.0
7.5
8.5
10

1.0 ± 0.21
1.1 ± 0.31
1.2 ± 0.30
1.2 ± 0.24
1.3 ± 0.29
1.2 ± 0.26

12
47
95
39
53
14

* The LtxA conductance (G ± variance/SD) in each 1 M KCl solution was either taken from Gaussian distributions
(see Figure 9) or directly from the statistics of single-channel data (n number of single events). To analyze the
conductance in each case, n channels were reconstituted in asolectin/n-decane membranes at 20 mV voltage at 20 ◦ C.
The number of events analyzed at pH 3.7 and 10 was low due to the instability of the lipid bilayers at extreme
pH values.

3. Discussion
Leukocytes need to rapidly move from blood vessels to tissues upon inflammation or infection.
A crucial mechanism regulating this process is the subcellular trafficking of adhesion molecules,
primarily integrins [47]. Integrins undergo constant endo/exocytic turnover, necessary for the dynamic
regulation of cell adhesion. Bacterial toxins have developed a number of schemes to cross the membrane
in order to enter the cell. LtxA evolved the strategy to target specifically β2 integrin LFA-1 on leukocytes’
surface [22]. This binding is required for toxin internalization [23].
We here report that LtxA is delivered to the cytosol of Jn.9 cells through endocytic trafficking.
Historically, endocytic pathways are classified as either clathrin-dependent or clathrin-independent.
The large GTPase dynamin [48] is hypothesized to be directly involved in closing off endocytic
vesicles from the plasma membrane. The key players in the formation of clathrin-coated vesicles
are dynamin [48] and adaptor proteins [49]. The studies with Mannheimia haemolytica LktA, another
RTX leukotoxin, show that LktA is internalized in a dynamin-2 and clathrin-dependent manner [50].
The following LktA-trafficking events involve the toxin binding to the mitochondria and interaction
with cyclophilin D, a mitochondrial chaperone protein, in bovine lymphoblastoid cells [51].
Our data indicate that LtxA enters Jn.9 cells using a clathrin-independent mechanism
(or predominantly uses this pathway). Our results correlate with the finding that LFA-1 is internalized
through a clathrin-independent, cholesterol-dependent pathway and this process is essential for
cell migration [52]. In this scenario, non-clathrin-coated lipid raft microdomains form 50–100 nm
flask-shaped vesicles in the plasma membrane regions rich in lipid rafts [53]. Lipid-raft dependent
endocytosis was shown to be dynamin-dependent [54] and may involve caveolae formation. Thus,
we hypothesize that LtxA/LFA-1 is endocytosed through caveolae-mediated endocytosis.
Bacterial toxins often piggyback existing endocytic trafficking pathways [55,56] to deliver active
proteins to subcellular targets. The small GTPases Rab are essential regulators of intracellular
membrane trafficking and exist in an inactive GDP-bound form and an active GTP-bound form [57].
The co-localization experiments with Rab5, Rab7, Lamp1 revealed that LtxA can follow the degradation
pathway process that culminates in the delivery of the toxin to lysosomes. Rab5 localizes to early
endosomes where it is involved in the recruitment of Rab7 and the maturation of these compartments
to late endosomes [58]. Impaired Rab5a function affects endo- and exocytosis rates and, conversely,
Rab5 overexpression increases the release efficacy [59]. Therefore, the termination of Rab5 function
blocks the movement of proteins downstream of the endocytic pathway. Downregulation of Rab5a
decreased LtxA toxicity, suggesting that further toxin trafficking is required for intoxication by LtxA.
LFA-1 was suggested to undergo endocytic recycling through the long-Rab11A-dependent pathway
with a transitional step at PNRC [29]. Here we, for the first time, demonstrated CD11a localization
in Rab11A-containing endocytic vesicles. Extensive colocalization of CD11a and Rab11A was found
in Jn.9 cells which were not treated with LtxA (Figure S10). While some LtxA follows LFA-1 in its
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recycling turnover, a portion of LtxA is separated from LFA-1 and the toxin proceeds to late endosomes
and lysosomes. A proposed model of LtxA trafficking in lymphocytes is shown in Figure 10.
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Here, we demonstrate that LtxA causes changes in lysosomal pH in T lymphocytes, however, to a
leser extent. As the Lysotracker dye is sensitive to luminal pH, the decrease in the dye staining could
have resulted from either a rise in lysosomal pH or a decrease in the number of lysosomes. To
distinguish between these possibilities, cells were stained for lysosomal marker Lamp1. The clear
decrease in Lamp1 staining, combined with the decrease in the Lysotracker signal, forms a strong
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LtxA causes changes in lysosomal pH in T lymphocytes, however, to a leser extent. As the Lysotracker
dye is sensitive to luminal pH, the decrease in the dye staining could have resulted from either a rise in
lysosomal pH or a decrease in the number of lysosomes. To distinguish between these possibilities,
cells were stained for lysosomal marker Lamp1. The clear decrease in Lamp1 staining, combined
with the decrease in the Lysotracker signal, forms a strong argument that the toxin decreased the
number of lysosomes. As the transcription factor EB (TFEB) feedback systems try to increase lysosomal
biogenesis [65], the most likely explanation for this is that the toxin has ruptured the lysosomes and
overridden the TFEB pathways. The pore-forming properties of LtxA are well established [32,46].
Therefore, we propose that LtxA can cause permeabilization of the lysosomal membrane, and possibly
other intracellular organelles after the toxin is released from lysosomes.
LtxA was reported to cause different cellular responses leading to cell death in LFA-1-expressing
cells. Kelk et al. reported that LtxA lyses healthy monocytes by the activation of inflammatory caspase
1 and causes release of IL-1b and IL-18. In contrast to myeloid cells, LtxA uses a “slow mode” of
lymphocyte killing. The killing of malignant lymphocytes requires Fas receptors and caspase 8 in
both T and B lymphocytes [66]. In B lymphocytes (JY cells), LtxA caused loss of the mitochondrial
membrane potential, cytochrome c release, reactive oxygen species release, and activation of caspases
3,7,9 [24]. One possible explanation for the cell death mechanism induced by LtxA is the degree of
lysosomal damage caused by the toxins in the cell. The extent of lysosomal rupture will determine
morphological outcomes following lysosomal membrane permeabilization. Extensive lysosomal injury
may lead to necrotic cell death, while less substantial damage to lysosomes may instigate several
apoptotic pathways, which can be attenuated by the inhibition of lysosomal cathepsins [66–69].
The planar lipid bilayer assay is a highly sensitive method that allows the characterization
of the membrane damaging activity of RTX-toxins in different physical conditions [70]. A current
model proposes that RTX-toxins form cation-selective channels with a diameter of 0.6–2.6 nm in
artificial membranes formed of lipid mixtures such as the asolectin/n-decane membrane [46]. It was
demonstrated that the membrane-damaging activity of LtxA in artificial bilayers did not require
the presence of the receptor [71]. In the endocytic pathway, subsequent acidification may initiate
proteolysis and conformational changes, resulting in the ability of toxins and viruses to cross the
endocytic vesicle membrane, since drugs that interfere with the endosomal pH are able to block the
infection [72,73]. In this study, we used this method to observe and compare the pore formation
of LtxA at different pH. We demonstrated that LtxA is functional in acidic pH found in endocytic
vesicles and lysosomes, which may result in their damage. RTX toxins are intrinsically disordered
proteins, therefore changes in pH may affect their secondary structure and consequently change their
activity [74]. Further investigation is required to improve our understanding of the intracellular events
leading to LtxA-induced cytolysis.
In conclusion, our results show that LtxA enters the cytosol of Jurkat cells without evidence
of plasma membrane damage, utilizing receptor-mediated endocytic mechanisms. In our studies,
colocolization between LtxA/CD11a was demonstrated on the plasma membrane [23] and in the
early steps of LtxA endocytic trafficking. Our results suggest that LtxA can accompany LFA-1 in its
recycling pathway; however, the toxin molecules can apparently dissociate from the receptor in an
acidic environment of endocytic vesicles and independently follow the degradative pathway. LtxA
delivery to the terminal point of this route results in the lysosomal membrane rupture.
4. Materials and Methods
4.1. Antibodies and Chemicals
The following primary antibodies were used; CD11a Alexa Fluor™ 594 clone HI111 (Biolegend,
San Diego, CA), rabbit polyclonal anti-Rab5, anti-Rab11A, anti-Rab7, or anti-Lamp1 antibody (Abcam,
Cambridge, UK), anti-beta-actin antibody (AnaSpec, Fremont, CA) (1:1000), and anti-LtxA monoclonal
antibody 107A3A3 [75] in hybridoma supernatants (1:10 dilution). The following secondary antibodies
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were used: goat anti-rabbit IgG Alexa Fluor® 488 (1:1000); horseradish peroxidase (HRP)-conjugated
goat anti-mouse IgG (Fc) or (HRP)-goat anti-rabbit (Pierce, Rockford, IL) (1:10,000). Transferrin labeled
with Alexa Fluor®555 was from Invitrogen (Waltham, MA, USA). Dynamin inhibitor Dynole 34-2 and
its inactive control, Dynole 31-2, were purchased from SigmaAldrich (St. Louis, MO), Dynasore and
Pitstop 2 (Abcam, Cambridge, UK). The inhibitors were used in the following concentrations: 10 µM
Dynole 34-2; 10 µM Dynole 31-2; 10 µM Dynasore; 5 µM Pitstop 2.
4.2. Cell Culture
Jn.9, a subclone of Jurkat cells [76] was utilized in this study. The cells were cultivated in RPMI
1640 medium containing 10% FBS, 0.1 mM MEM non-essential amino acids, 1x MEM vitamin solution,
and 2 mM L-glutamine, and 0.5 µg/mL gentamicin at 37 ◦ C under 5% CO2 .
4.3. LtxA Purification and Labeling
Aa strain JP2 [77] was grown on solid AAGM medium [78] for 48 h at 37 ◦ C in 10% CO2 atmosphere.
The colony was then inoculated in 1.5 L of liquid AAGM medium and the culture was incubated for
18 h. The toxin was purified from cell culture supernatants as described previously [79]. Purified
LtxA was labeled with DyLight™ 650 (LtxA-DY650) or DyLight™ 488 (LtxA-DY488) using DyLight™
Amine-Reactive dyes (Pierce). The toxin was purified after labeling using a Zeba™ Spin Desalting
column (40 K MWCO, Thermo Fisher™ Scientific), according to previously published protocol [23].
4.4. Immunofluorescence
For LtxA trafficking studies, 1 × 106 of Jn.9 cells were incubated with 20 nM LtxA-DY650 for
15 min to 2 h at 37 ◦ C in the growth medium. The cells were then washed with PBS, fixed with 2%
paraformaldehyde for 10 min, washed twice with PBS, and permeabilized with 0.2% Triton X-100
for 20 min. The cells were subsequently blocked with 4% BSA for 30 min at 37 ◦ C, incubated with
primary antibody for 18 h at 4 ◦ C, washed, and incubated with secondary antibody conjugated to
Alexa Fluor 488 for 1 h at 37 ◦ C. The nuclei were stained with 1 µg/ml Hoechst 33342 (Molecular
Probes™, Eugene, OR) for 15 min at 37 ◦ C. Samples were mounted in Cytoseal mounting medium
(Electron Microscopy Sciences, Hatfield, PA) and images captured with a Nikon A1R laser scanning
confocal microscope (Nikon Instruments Inc., Melville, NY ) with a PLAN APO VC 60 × water (NA 1.2)
objective at 18 ◦ C. Data were analyzed using Nikon Elements AR 4.30.01 software. For co-distribution
analyses, the Pearson’s’ coefficient of 0.55 was used as a cut off and was identified using circular
ROIs. A Z-stack series consisting of seventeen individual planes 0.33 µm apart were assembled in 3D
animations using Nikon Elements AR 4.30.01 software. Maximum intensity projection and standard
LUT adjustment were used for the images’ presentation.
For live imaging of LtxA uptake, Jn.9 cells were washed with in the serum free medium and were
placed to attach for 20 min in ibiTreat 60 µ-dishes (Ibidi, Madison, WI) coated with poly-l-lysine (Sigma
St. Louis, MO, USA). After floating cells were removed, the attached cells were pretreated with specific
inhibitor, if necessary, and 20 nM LtxA-DY650 or 1 µM transferrin labeled with Alexa Fluor®555 was
added. The cells were examined using a Nikon A1R laser scanning confocal microscope with a 60×
water objective at different intervals of treatment at 37 ◦ C.
4.5. Inhibitors
Chemicals stocks were prepared in DMSO and were added in the 1 µl volume to 1 ml of cells.
To measure LtxA internalization inhibition, Jn.9 cells (1 × 106 cells) were pre-incubated with 5–10 µM
inhibitors for 20 min in the serum free medium at 37 ◦ C and then 20 nM LtxA-488 was added for
30 min. The effect of intracellular K+ -depletion was evaluated using previously published protocol [80].
Pelleted Jn.9 cells (1 × 106 cells) were incubated in 2 ml hypotonic medium (RPMI/water, 1:1) for 5 min,
followed by incubation in isotonic K+ -free buffer (50 mM Hepes and 100 mM NaCl at pH 7.4) for
40 min at 37 ◦ C, and then 20 nM LtxA-488 was added for 30 min. The toxin internalization assay was
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performed as described in the “Flow cytometry” section. Live imaging of LtxA uptake was performed as
described in the “Immunofluorescence” section. For cytotoxicity evaluation, the cells were treated with 2
nM LtxA and cell viability was evaluated as described in the “Cytotoxicity assay” section. The cells
treated with specific inhibitors alone served as a control
4.6. Flow Cytometry
YO-PRO®-1 and PI internalization was investigated using Membrane permeability/dead cell
apoptosis kit (Invitrogen, Carlsbad, CA) according to the manufacture’s protocol. Jn.9 cells (1 × 106 )
were treated with 20 nM LtxA at 37 ◦ C in Jn.9 culture medium at indicated times, washed with PBS
and then treated with 0.1 µM YO-PRO®-1 or 1.5 µM PI, followed by flow cytometry analysis. To detect
internalized LtxA, Jn.9 cells (1 × 106 cells) were incubated with 20 nM LtxA-DY488 for the specified
time on ice or at 37 ◦ C in Jn.9 culture medium, washed with PBS, and total cell-associated fluorescence
was analyzed. To quench the extracellular fluorescence, LtxA-DY488-treated cells were incubated with
0.025% trypan blue (Sigma, St. Louis, MO) for 20 min as described previously [42,45]. To quench the
intracellular fluorescence cells were permeabilized using 0.1% Triton X-100 (SigmaArdrich, St. Louis,
MO) for 10 min and then subjected to 0.025% trypan blue treatment. Fluorescence was measured
using a BD LSR II flow cytometer (BD Biosciences). Ten thousand events were recorded per sample,
and MCF values were determined using WinList™ 7.0 software (Verity Software House). No residual
fluorescence was detected in 0.1% Triton X-100 permeabilized cells after the trypan blue treatment.
Samples that were not treated with LtxA or LtxA-DY488 served as a control.
For lysosomal staining analysis, Jn.9 cells were incubated with 20 nM LtxA for 2 h at 37 ◦ C in the
growth medium. Then 100 nM LysoTracker® Green DND-26 (Life Technologies, Carlsbad, CA, USA)
was added to LtxA-treated and control cells for 15 min.
4.7. Protein Analyses
The protein concentration was determined by absorption at 280 nm on A1 NanoDrop
spectrophotometer (Thermo Fisher Scientific, Waltham, MA). Proteins were resolved on 4% to
20% SDS-PAGE and visualized by staining with GelCode blue stain reagent (Pierce, Rockford, IL).
The Western blot analysis was performed as described previously [70].
4.8. siRNA
The validated Silencer®Select siRNA targeting human Rab5a (ID s11678) and Silencer® Select
Negative Control #2 siRNA (catalog# 4390846) were synthesized by Life Technology (Carlsbad, CA,
USA). Jn.9 cells were transfected with lipofectamine 2000 (Life Technologies, Carlsbad, CA, USA)
according to the manufacturer’s instructions. For each transfection, 5 µl of the 20 µM siRNA stocks
were added to 400 µl of Jn.9 cells grown to 90% confluency. Rab5a levels in 1 x 106 Jn.9 cells were
confirmed by Western blot analysis 24 h after transfection. β-actin served as a loading control.
4.9. Cytotoxicity Assay
For toxicity tests, 2–20 nM LtxA was added to 1 x 106 Jn.9 cells in growth medium and incubated
for 18 h at 37 ◦ C. The cell membrane permeability was determined with trypan blue assay using Vi-cell
Cell Viability Analyzer (Beckman Coulter, Miami, FL). All reactions were run in duplicate; the assay
was performed three independent times. Untreated cells were used as controls.
4.10. Planar Lipid Bilayers
Lipid bilayer measurements have been described previously in detail [81]. In short, A Teflon
chamber, containing two 5 mL compartments connected by a small circular hole with a surface area
of about 0.4 mm2 , were filled with 1 M KCl, 10 mM MES, pH 6.0. Black lipid bilayer membranes
were created by painting onto the hole solutions of 1% (w/v) asolectin (phospholipids from soybean,

Pathogens 2020, 9, 74

19 of 23

Sigma-Aldrich) in n-decane. The temperature was maintained at 20 ◦ C during all experiments.
The current across the membrane was measured with a pair of Ag/AgCl electrodes with salt bridges
switched in series with a voltage source and current amplifier Keithley 427 (Keithley Instruments, INC.
Cleveland, OH). The amplified signal was recorded by a strip chart recorder (Rikadenki Electronics
GmbH, Freiburg, Germany).
4.11. Statistical Analysis
The statistical analyses were performed using either Student’s test or one-way analysis of variance
using SigmaPlot® (Systat Software, Inc. Chicago, IL, USA). The following statistical criteria were
applied: p < 0.001, p < 0.05, and p < 0.01.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/2/74/s1,
Figure S1: “Confocal imaging of LtxA and CD11a in Jn.9 cells”; Figure S2: “Effect of inhibitors on transferrin
uptake by Jn.9 cells”; Figure S3: “Effect of 10 µM Dynasore on LtxA uptake by Jn.9 cells.”; Figure S4 “LtxA toxicity
on Jn.9 cells”; Figure S5 “Localization of LtxA in early endosomes of Jn.9 cells”; Figure S6: “Localization of LtxA
in Rab11A-positive endosomes of Jn.9 cells.”; Figure S7: “Localization of LtxA around nuclear membrane of Jn.9
cells”; Figure S8: “Images of late endosomes in Jn.9 cells”; Figure S9: “Images of lysosomes in Jn.9 cells”. Figure
S10: “Confocal imaging of CD11a trafficking in Jn.9 cells”.
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